Sunil Verma, Senior Vice President of Global Head of Oncology at AstraZeneca, shared on LinkedIn:

“Great to be at the Milken Institute Global Conference in Los Angeles!

The Milken Institute Global Conference stands as an unparalleled platform, bringing together leaders and innovators from diverse sectors to tackle the most pressing issues facing our world today.

This offers an opportunity to engage in cutting-edge discussion on healthcare, technology and much more, allowing us to innovate solutions for a better tomorrow.

This year on behalf of AstraZeneca I took part in a panel discussion called The Next Wave of Immunotherapy and Cancer Treatments. Engaging in such a thought-provoking discussion surrounding healthcare innovation is essential as we navigate through a time of rapid transformation.

This session covered the future landscape of immunotherapy, exploring advancements including cell-based strategies such as TIL cell and CAR-T therapy. We discussed implications of these developments for patients and the evolving landscape of cancer treatment.

I am excited to connect with other industry and healthcare leaders so we can all help shape a more positive future for those with cancer.”

Source: Sunil Verma/LinkedIn